# X4 Pharmaceuticals, Inc: Form 8-K, filed May 12, 2026

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: 8-K
- Filed: 2026-05-12
- Accepted by EDGAR: May 12, 2026, 16:21 ET
- Period: 2026-05-11
- Accession: 0001501697-26-000047
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000150169726000047/xfor-20260511.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000150169726000047/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000150169726000047/xfor-20260511.htm

Filed May 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001501697-26-000047. Last ingested by Listed: Nov 4, 2026, 16:53 ET. No prices; not investment advice.